Berlin: Bayer has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA, regulatory authority ...

Onco360®, the nation’s leading independent specialty pharmacy, has added Augtyro™ (repotrectinib) manufactured by Bristol ...

Johnson & Johnson submits sNDA to US FDA for Caplyta for prevention of relapse in schizophrenia: Titusville, New Jersey Wednesday, July 9, 2025, 14:00 Hrs [IST] Johnson & Johnson ...

When Ben Stokes insisted on the eve of the third Test that England were not 'stuck in our ways', he was talking about the ...

In a decision handed down on June 27, the U.S. Court of Appeals for the District of Columbia Circuit said it could not ...

16.09.2019: Perspectives - Use of the antipsychotic drug quetiapine to treat sleep disorders has become widespread, also in Norway.

Our findings suggest that cannabidiol might reduce seizure frequency and might have an adequate safety profile in children and young adults with highly treatment-resistant epilepsy. Randomised ...